Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
PF-06954522 is being co-developed by Pfizer and Sosei, utilizing Sosei's proprietary technology StaR during the development process
Selenium promotes proliferation of chondrogenic cell ATDC5 by increment of intracellular ATP content under serum deprivation
Our expert team utilizes validated separation and quantification methods to deliver accurate EE% and LC% data, helping you optimize your nanomedicines with confidence
If youre considering trying it, talk to your provider first
Next generation weight loss drugs for the prevention of cancer
Arthur JC, Perez-Chanona E, Mhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al
US$ 25.40
US$ 25.95
US$ 28.89
